RTP-based Locus Biosciences has completed its first-of-its-kind clinical trial of its CRISPR enhanced bacteriophage technology. The new approach to antibiotics has the potential to combat even germs that have developed multiple drug resistance to conventional antibiotics.
Read More
Pairwise plans to introduce new, tasty, long shelflife varieties of fruits and vegetables created with gene-editing. A $90 million B round plants the company in some firm ground.
Read More
Gene editing startup Locus Biosciences has landed another $7 million in new cash, adding to a year that has brought commitments of nearly $100 million.
Read More
Babies born with a faulty maternal copy of the UBE3A gene will develop Angelman syndrome, a severe neurodevelopmental disorder with no cure and limited treatments. Now, for the first time, scientists at the UNC School of Medicine show that gene editing and gene therapy techniques can be used to restore UBE3A in human neuron cultures and treat deficits in an animal model of Angelman syndrome.
Read More
The Nobel Prize in Chemistry has been awarded to Emmanuelle Charpentier and Jennifer A. Doudna for the development of a method for genome editing.
Read More
The round, which kicked off on April 8, is capped at $15 million, with $2.5 million remaining to be sold. Funds raised will be used fo “payments of salary in the ordinary course of business,” the filing indicated.
Read More
Jude Samulski, a pioneer in using small viruses to insert therapeutic genes into cells, has been awarded an international patent application by the World Intellectual Property Organization for his regulated gene-editing system.
Read More
Research at North Carolina State University shows that a gene editing system can be used to effectively target and eliminate specific gut bacteria, in this case Clostridioides difficile, the pathogen that causes colitis – a chronic, degenerative disease of the colon.
Read More
Scientists say they have used the gene editing tool CRISPR inside someone’s body for the first time, a new frontier for efforts to operate on DNA, the chemical code of life, to treat diseases. Here’s the latest plus a look at Triangle connections to CRISPR and gene editing.
Read More
